AFYX Therapeutics

About:

AFYX Therapeutics is a clinical stage biopharmaceutical company

Website: https://afyxtx.com/

Twitter/X: AFYX_Tx

Top Investors: Sofinnova Investments, Novo Holdings, EASME - EU Executive Agency for SMEs, Lundbeckfonden Emerge

Description:

AFYX Therapeutics is changing the way mucosal diseases are treated. They are a topical drug delivery company developing a pipeline of targeted treatments for conditions that currently lack approved therapy options. Their proprietary Rivelin® patch is flexible, biodegradable, and adhesive to mucosal surfaces. Designed with electrospinning technology, it delivers a therapeutic directly to the site in need, without interfering with patients’ daily activities.